![JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry](https://pub.mdpi-res.com/jcm/jcm-11-04845/article_deploy/html/images/jcm-11-04845-g002.png?1660897917)
JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
![Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/fd3a19ec-5995-4ca9-be7b-77818c08c13b/gr2ab.jpg)
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology
![Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. - Abstract - Europe PMC Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8941474/bin/advancesADV2021005808absf1.jpg)
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. - Abstract - Europe PMC
![The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e0654799-d970-48d0-8ad1-4c0d0fd6bd05/joim13022-toc-0001-m.jpg)
The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library
![ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram](https://www.researchgate.net/profile/Babak-Mohit/publication/353646752/figure/tbl1/AS:1052448680595456@1627934727634/Case-reports-of-acute-cerebrovascular-events-related-to-COVID-19_Q320.jpg)
ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram
![Cureus | Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome | Article Cureus | Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome | Article](https://assets.cureus.com/uploads/figure/file/275333/article_river_cdb793f031b311ec9fcae3b54cacc4b6-pathogenesis-of-aps.png)
Cureus | Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome | Article
![JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry](https://www.mdpi.com/jcm/jcm-11-04845/article_deploy/html/images/jcm-11-04845-g003-550.jpg)
JCM | Free Full-Text | Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
![ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram](https://www.researchgate.net/publication/283811557/figure/fig1/AS:296798842310656@1447773766035/ASTRO-APS-study-design-ASTRO-APS-indicates-Apixaban-for-the-Secondary-Prevention-of.png)
ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram
![Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/6095d0ef-06f7-4224-9e94-0f28f8a2f8e2/gr5.jpg)
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology
![Frontiers | Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines Frontiers | Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines](https://www.frontiersin.org/files/Articles/715878/fcvm-08-715878-HTML/image_m/fcvm-08-715878-g001.jpg)
Frontiers | Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
![Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - ScienceDirect Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S073510972207098X-fx1.jpg)
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - ScienceDirect
![Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial - ScienceDirect Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921007515-grabsf1.jpg)
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial - ScienceDirect
Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Control
![ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram](https://www.researchgate.net/profile/James-Lloyd-13/publication/283811557/figure/fig1/AS:296798842310656@1447773766035/ASTRO-APS-study-design-ASTRO-APS-indicates-Apixaban-for-the-Secondary-Prevention-of_Q320.jpg)
ASTRO-APS study design. ASTRO-APS indicates Apixaban for the Secondary... | Download Scientific Diagram
![Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - ScienceDirect Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S073510972207098X-gr1.jpg)